gene in clients relapsing soon after treatment method While using the BCL2 antagonist venetoclax. sixty six Resistance to those agents has become connected to these mutations in all over 70% of scenarios, While they usually are subclonal as well as their certain part creating resistance must be confirmed.??? "???????????????????????????????????????